HIGHLIGHTS
- who: Hui-Sheng Chen from the ChinaLMU Munich University have published the research work: Intravenous thrombolysis with 0.65 mg/kg r-tPA may be optimal for Chinese mild-to-moderate stroke, in the Journal: (JOURNAL)
- what: Given the possible dose-related difference in effectiveness and safety in a different population, the optimal dose of r-tPA has been a research focus. The study showed a similar rate of sICH in the 0.65 mg/kg group and 0.90 mg/kg group, which was consistent with a recent meta-analysis . This study investigated the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.